Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Clinical Study of STR-P005 for Relapsed/Refractory Autoimmune Diseases
NCT07605637Not yet recruiting
- Sponsor
- Beijing Gaobo Hospital
- Start
- Jun 2026
- Primary completion
- May 2027
- Modality
- CAR-T Cells, mRNA Therapeutics
01
Overview
Open-label, single-arm trial of STR-P005 in autoimmune disease, sponsored by Beijing Gaobo Hospital. Primary endpoint: Number of participants with treatment-related adverse events at 12 months. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
STR-P005
03
Conditions
autoimmune disease
Beyond the preview
Go deeper on NCT07605637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07605637.